Key result
Ewing sarcoma survivors experienced a 35-year survival rate of 70% (95% CI, 66%-74%), with high cumulative incidences of subsequent neoplasms (24.0%) and chronic conditions (84.6%).
Cohort (n=404)
Authors
No takes yet. Share an insight, caveat, or question.
Substantial late morbidity persists among Ewing sarcoma survivors; leaves open optimal surveillance and prevention strategies.
Marina et al. (2017) conducted a cohort in Ewing sarcoma (n=404). Ewing sarcoma survivorship was evaluated on 35-year survival rate (95% CI 66-74). Ewing sarcoma survivors experienced a 35-year survival rate of 70% (95% CI, 66%-74%), with high cumulative incidences of subsequent neoplasms (24.0%) and chronic conditions (84.6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: